Novel Mechanisms of Beta-lactam Resistance in Staph Aureus

金黄色葡萄球菌β-内酰胺耐药的新机制

基本信息

  • 批准号:
    10318974
  • 负责人:
  • 金额:
    $ 65.37万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-08-01 至 2024-06-30
  • 项目状态:
    已结题

项目摘要

Abstract We have identified a novel mode of high-level, broad-spectrum β-lactam resistance in S. aureus that is not mediated by PBP2a, the penicillin-binding protein (PBP) that confers methicillin resistance. PBP4, a non- essential PBP, and GdpP, the only known phosphodiesterase (PDE) that mediates cyclic-di-adenosine-mono- phosphate (CDA) degradation, have critical roles in this type of resistance. Mutations that enhance PBP4's ability to make a highly cross-linked bacterial cell wall and loss-of-function mutations in GdpP are the genetic basis responsible for this uncanonical resistance. The highly cross-linked cell wall formation is driven either independently or cooperatively by two distinct biochemical features of PBP4, a) structural changes in its protein due to missense mutations and b) its overexpression due to mutations in its promoter region. The loss-of-function mutations in GdpP result in elevated concentrations of CDA in bacterial cells. CDA is a newly discovered cell-signaling second messenger in bacteria which acts as an allosteric regulator by binding to its effectors (proteins and RNAs). CDA broadly affects gene expression and controls GdpP related β-lactam resistant phenotypes in a concentration dependent manner, suggesting that it is the deterministic factor in resistance. However, the precise role(s) of CDA in mediating β-lactam resistance as well as other vital processes of S. aureus is currently unknown. These functional alterations of PBP4 and GdpP likely come at the cost of bacterial virulence due to depletion of cell wall associated proteins and attenuated production of cytolysins, respectively. This indicates a unique yin-yang relationship between two key pathogenic factors of S. aureus, β-lactam resistance and virulence. We will investigate the fundamental basis of the functional changes in PBP4 and GdpP that lead to resistance and their impact on bacterial virulence. Aim 1: To determine the mechanism of PBP4-mediated β-lactam resistance and the role of PBP4 in cell wall composition. The relative contribution of PBP4 missense and promoter mutations on cell wall synthesis will be evaluated biochemically and structurally. The mechanism(s) that control pbp4 expression will be investigated to identify regulator(s) and to determine how they confer PBP4-mediated β-lactam resistance. PBP4's role on bacterial cell surface associated virulence factor expression will be determined. Aim 2: To define the role of cyclic-di-adenosine-mono-phosphate (CDA) signaling in S. aureus. Genetic and chemical proteomic approaches will be taken to identify CDA mediator/s in the bacteria that are responsible for β-lactam resistance and virulence defect. Finally, our preliminary data suggest the presence of a novel CDA specific phosphodiesterase in S. aureus besides GdpP. We will identify this novel phosphodiesterase. The proposed research will advance knowledge of basic cellular processes in S. aureus.
摘要

项目成果

期刊论文数量(18)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Ceftaroline-Resistant, Daptomycin-Tolerant, and Heterogeneous Vancomycin-Intermediate Methicillin-Resistant Staphylococcus aureus Causing Infective Endocarditis.
头孢洛林耐药、达托霉素耐受和异种万古霉素中间甲氧西林耐药金黄色葡萄球菌引起感染性心内膜炎。
  • DOI:
    10.1128/aac.01235-16
  • 发表时间:
    2017
  • 期刊:
  • 影响因子:
    4.9
  • 作者:
    Nigo,Masayuki;Diaz,Lorena;Carvajal,LinaP;Tran,TrucT;Rios,Rafael;Panesso,Diana;Garavito,JuanD;Miller,WilliamR;Wanger,Audrey;Weinstock,George;Munita,JoseM;Arias,CesarA;Chambers,HenryF
  • 通讯作者:
    Chambers,HenryF
In Vivo Detection of Cyclic-di-AMP in Staphylococcus aureus.
  • DOI:
    10.1021/acsomega.2c04538
  • 发表时间:
    2022-09-13
  • 期刊:
  • 影响因子:
    4.1
  • 作者:
    Mukkayyan, Nagaraja;Poon, Raymond;Sander, Philipp N.;Lai, Li-Yin;Zubair-Nizami, Zahra;Hammond, Ming C.;Chatterjee, Som S.
  • 通讯作者:
    Chatterjee, Som S.
PBP4-mediated β-lactam resistance among clinical strains of Staphylococcus aureus.
金黄色葡萄球菌临床菌株中 PBP4 介导的 β-内酰胺耐药性。
  • DOI:
    10.1093/jac/dkab201
  • 发表时间:
    2021
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Satishkumar,Nidhi;Alexander,JAndrewN;Poon,Raymond;Buggeln,Emma;Argudín,MariaA;Strynadka,NatalieCJ;Chatterjee,SomS
  • 通讯作者:
    Chatterjee,SomS
A Nonclassical Mechanism of β-Lactam Resistance in Methicillin-Resistant Staphylococcus aureus and Its Effect on Virulence.
  • DOI:
    10.1128/spectrum.02284-22
  • 发表时间:
    2022-12-21
  • 期刊:
  • 影响因子:
    3.7
  • 作者:
  • 通讯作者:
Structural basis of broad-spectrum β-lactam resistance in Staphylococcus aureus.
  • DOI:
    10.1038/s41586-022-05583-3
  • 发表时间:
    2023-01
  • 期刊:
  • 影响因子:
    64.8
  • 作者:
    Alexander, J. Andrew N.;Worrall, Liam J.;Hu, Jinhong;Vuckovic, Marija;Satishkumar, Nidhi;Poon, Raymond;Sobhanifar, Solmaz;Rosell, Federico I.;Jenkins, Joshua;Chiang, Daniel;Mosimann, Wesley A.;Chambers, Henry F.;Paetzel, Mark;Chatterjee, Som S.;Strynadka, Natalie C. J.
  • 通讯作者:
    Strynadka, Natalie C. J.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Som Chatterjee其他文献

Som Chatterjee的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Som Chatterjee', 18)}}的其他基金

Serine/threonine kinase signaling in beta-lactam resistance of Staphylococcus aureus
金黄色葡萄球菌 β-内酰胺耐药中的丝氨酸/苏氨酸激酶信号传导
  • 批准号:
    10582130
  • 财政年份:
    2023
  • 资助金额:
    $ 65.37万
  • 项目类别:
Novel Mechanisms of Beta-lactam Resistance in Staph Aureus
金黄色葡萄球菌β-内酰胺耐药的新机制
  • 批准号:
    10078841
  • 财政年份:
    2012
  • 资助金额:
    $ 65.37万
  • 项目类别:

相似海外基金

Construction of affinity sensors using high-speed oscillation of nanomaterials
利用纳米材料高速振荡构建亲和传感器
  • 批准号:
    23H01982
  • 财政年份:
    2023
  • 资助金额:
    $ 65.37万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Affinity evaluation for development of polymer nanocomposites with high thermal conductivity and interfacial molecular design
高导热率聚合物纳米复合材料开发和界面分子设计的亲和力评估
  • 批准号:
    23KJ0116
  • 财政年份:
    2023
  • 资助金额:
    $ 65.37万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Development of High-Affinity and Selective Ligands as a Pharmacological Tool for the Dopamine D4 Receptor (D4R) Subtype Variants
开发高亲和力和选择性配体作为多巴胺 D4 受体 (D4R) 亚型变体的药理学工具
  • 批准号:
    10682794
  • 财政年份:
    2023
  • 资助金额:
    $ 65.37万
  • 项目类别:
Platform for the High Throughput Generation and Validation of Affinity Reagents
用于高通量生成和亲和试剂验证的平台
  • 批准号:
    10598276
  • 财政年份:
    2023
  • 资助金额:
    $ 65.37万
  • 项目类别:
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
  • 批准号:
    2233343
  • 财政年份:
    2023
  • 资助金额:
    $ 65.37万
  • 项目类别:
    Standard Grant
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
  • 批准号:
    2233342
  • 财政年份:
    2023
  • 资助金额:
    $ 65.37万
  • 项目类别:
    Standard Grant
Molecular mechanisms underlying high-affinity and isotype switched antibody responses
高亲和力和同种型转换抗体反应的分子机制
  • 批准号:
    479363
  • 财政年份:
    2023
  • 资助金额:
    $ 65.37万
  • 项目类别:
    Operating Grants
Deconstructed T cell antigen recognition: Separation of affinity from bond lifetime
解构 T 细胞抗原识别:亲和力与键寿命的分离
  • 批准号:
    10681989
  • 财政年份:
    2023
  • 资助金额:
    $ 65.37万
  • 项目类别:
CAREER: Engineered Affinity-Based Biomaterials for Harnessing the Stem Cell Secretome
职业:基于亲和力的工程生物材料用于利用干细胞分泌组
  • 批准号:
    2237240
  • 财政年份:
    2023
  • 资助金额:
    $ 65.37万
  • 项目类别:
    Continuing Grant
ADVANCE Partnership: Leveraging Intersectionality and Engineering Affinity groups in Industrial Engineering and Operations Research (LINEAGE)
ADVANCE 合作伙伴关系:利用工业工程和运筹学 (LINEAGE) 领域的交叉性和工程亲和力团体
  • 批准号:
    2305592
  • 财政年份:
    2023
  • 资助金额:
    $ 65.37万
  • 项目类别:
    Continuing Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了